A. Domínguez‐Gil

1.8k total citations
148 papers, 1.4k citations indexed

About

A. Domínguez‐Gil is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, A. Domínguez‐Gil has authored 148 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pharmacology, 32 papers in Pediatrics, Perinatology and Child Health and 32 papers in Oncology. Recurrent topics in A. Domínguez‐Gil's work include Antibiotics Pharmacokinetics and Efficacy (61 papers), Drug Transport and Resistance Mechanisms (26 papers) and Analytical Methods in Pharmaceuticals (23 papers). A. Domínguez‐Gil is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (61 papers), Drug Transport and Resistance Mechanisms (26 papers) and Analytical Methods in Pharmaceuticals (23 papers). A. Domínguez‐Gil collaborates with scholars based in Spain, United Kingdom and Italy. A. Domínguez‐Gil's co-authors include María José García Sánchez, José Luís Pedraz, María Victoria Martínez Calvo, Dolores Santos Buelga, José M. Lanao, María José Otero, Carla Caramella, Eduardo L. Mariño, Silvia Rossi and Maria Cristina Bonferoni and has published in prestigious journals such as Journal of Controlled Release, Kidney International and Antimicrobial Agents and Chemotherapy.

In The Last Decade

A. Domínguez‐Gil

140 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Domínguez‐Gil Spain 19 513 355 211 152 149 148 1.4k
Robert E. Weinfeld United States 23 541 1.1× 344 1.0× 301 1.4× 201 1.3× 250 1.7× 34 1.6k
Rick Davis United States 14 470 0.9× 293 0.8× 335 1.6× 99 0.7× 207 1.4× 25 1.5k
Hartmut Derendorf United States 20 417 0.8× 144 0.4× 65 0.3× 133 0.9× 112 0.8× 45 1.7k
Alison H. Thomson United Kingdom 27 831 1.6× 415 1.2× 175 0.8× 233 1.5× 390 2.6× 78 2.5k
Bruce Charles Australia 30 558 1.1× 619 1.7× 115 0.5× 380 2.5× 221 1.5× 82 2.4k
Koen Boussery Belgium 27 332 0.6× 362 1.0× 199 0.9× 141 0.9× 239 1.6× 142 2.7k
Mario L. Rocci United States 24 360 0.7× 322 0.9× 77 0.4× 256 1.7× 99 0.7× 73 2.1k
Todd W.B. Gehr United States 36 223 0.4× 182 0.5× 83 0.4× 82 0.5× 271 1.8× 105 3.4k
James D. Hulse United States 18 410 0.8× 185 0.5× 115 0.5× 155 1.0× 158 1.1× 31 2.2k
Donald Perrier United States 23 358 0.7× 341 1.0× 155 0.7× 216 1.4× 83 0.6× 53 1.6k

Countries citing papers authored by A. Domínguez‐Gil

Since Specialization
Citations

This map shows the geographic impact of A. Domínguez‐Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Domínguez‐Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Domínguez‐Gil more than expected).

Fields of papers citing papers by A. Domínguez‐Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Domínguez‐Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Domínguez‐Gil. The network helps show where A. Domínguez‐Gil may publish in the future.

Co-authorship network of co-authors of A. Domínguez‐Gil

This figure shows the co-authorship network connecting the top 25 collaborators of A. Domínguez‐Gil. A scholar is included among the top collaborators of A. Domínguez‐Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Domínguez‐Gil. A. Domínguez‐Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Domínguez‐Gil, A., et al.. (2011). PSS20 Annual Cost of Biological Therapies for the Treatment of Moderate to Severe Plaque Psoriasis in Spain. Value in Health. 14(7). A505–A505. 3 indexed citations
2.
Molina, Vicente, et al.. (2008). Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(4). 948–954. 21 indexed citations
3.
Rubio-Terrés, Carlos, et al.. (2004). Análisis farmacoeconómico del tratamiento de pacientes con exacerbación aguda de la bronquitis crónica con telitromicina o cefuroxima-axetilo. Revista Clínica Española. 204(11). 567–573. 2 indexed citations
4.
Rubio-Terrés, Carlos, et al.. (2003). Análisis farmacoeconómico del tratamiento de la artritis reumatoide resistente a metotrexato con las combinaciones de leflunomida-metotrexato o infliximab-metotrexato. 30(1). 4–11.
5.
Domínguez‐Gil, A., et al.. (2000). Acontecimientos adversos por medicamentos: una patología emergente. Farmacia Hospitalaria. 24(4). 258–266. 51 indexed citations
6.
Otero, María José, et al.. (1999). Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data. Biopharmaceutics & Drug Disposition. 20(5). 233–240. 51 indexed citations
7.
Romano, Silvia, et al.. (1999). Population pharmacokinetics of amikacin in patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. 44(2). 235–242. 56 indexed citations
8.
Pérez-Encinas, Montserrat, et al.. (1998). Multicriteria decision analysis for determining drug therapy forintermittent claudication. Methods and Findings in Experimental and Clinical Pharmacology. 20(5). 425–425. 5 indexed citations
9.
Otero, María José, Dolores Santos Buelga, Martha Vâzquez, M. Barrueco, & A. Domínguez‐Gil. (1996). Application of population pharmacokinetics to the optimization of theophylline therapy. Journal of Clinical Pharmacy and Therapeutics. 21(2). 113–125. 18 indexed citations
10.
Calvo, María Victoria Martínez, et al.. (1996). Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies. Clinical Pharmacology & Therapeutics. 60(3). 332–340. 70 indexed citations
11.
Domínguez‐Gil, A.. (1993). Contribution of biopharmaceutics and pharmacokinetics to improve drug therapy. European Journal of Drug Metabolism and Pharmacokinetics. 18(1). 1–5. 4 indexed citations
12.
González, J. L., et al.. (1992). Evaluation of Thermodynamic Lonization Constants by Computation of Spectrophotometric and Potentiometric Experimental Data Obtained Simultaneously from a Flow System. Journal of Pharmaceutical Sciences. 81(6). 592–596. 10 indexed citations
13.
Sánchez, María José García, et al.. (1992). Population pharmacokinetics of imipramine in children. European Journal of Clinical Pharmacology. 43(1). 89–92. 7 indexed citations
14.
Lanao, José M., et al.. (1992). A Computer Program(DCN) for Numerical Convolution and Deconvolution of Pharmacokinetic Functions.. Journal of Pharmacobio-Dynamics. 15(5). 203–214. 3 indexed citations
15.
Lanao, José M., et al.. (1991). Distribution kinetics of netilmicin in human blister fluid: Effect of renal impairment. Biopharmaceutics & Drug Disposition. 12(2). 149–162. 2 indexed citations
16.
Berrocal, Alfonso, et al.. (1989). POPULATION PHARMACOKINETIC STUDY OF GENTAMICIN AND A BAYESIAN APPROACH IN PATIENTS WITH RENAL IMPAIRMENT. Journal of Clinical Pharmacy and Therapeutics. 14(3). 213–223. 5 indexed citations
17.
Otero, María José, Arturo Farfán Martín, M. Barrueco, María José García Sánchez, & A. Domínguez‐Gil. (1988). TDM OF THEOPHYLLINE—COMPLIANCE EVALUATION. Journal of Clinical Pharmacy and Therapeutics. 13(4). 273–280. 2 indexed citations
18.
Sánchez, María José García, et al.. (1988). COMPARISON OF METHODS OF CARBAMAZEPINE DOSAGE, INDIVIDUALIZATION IN EPILEPTIC PATIENTS. Journal of Clinical Pharmacy and Therapeutics. 13(6). 375–380. 10 indexed citations
19.
Domínguez‐Gil, A., et al.. (1981). The pharmacokinetics of cefadroxil associated with probenecid.. PubMed. 19(11). 506–8. 7 indexed citations
20.
Domínguez‐Gil, A., et al.. (1979). Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17(4). 171–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Weinfeld Breakdown of academic impact, for papers by Rick Davis Breakdown of academic impact, for papers by Hartmut Derendorf Breakdown of academic impact, for papers by Alison H. Thomson Breakdown of academic impact, for papers by Bruce Charles Breakdown of academic impact, for papers by Koen Boussery Breakdown of academic impact, for papers by Mario L. Rocci Breakdown of academic impact, for papers by Todd W.B. Gehr Breakdown of academic impact, for papers by James D. Hulse Breakdown of academic impact, for papers by Donald Perrier
Rankless by CCL
2026